Chiesi USA Inc - Company Profile

Powered by

All the data and insights you need on Chiesi USA Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Chiesi USA Inc Strategy Report

  • Understand Chiesi USA Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Chiesi USA Inc (Chiesi USA) is a subsidiary of Chiesi Farmaceutici SpA, is a pharmaceutical company that develops, researches, produces, and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics. The company's product portfolio comprises of Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Bethkis (tobramycin), Argatroban injection (Argatroban), Pertzye (pancrelipase), Kengreal (cangrelor), Cleviprex (clevidipine) and Retavase (reteplase). Its product pipeline encompasses drugs in key therapeutic areas of asthma, chronic obstructive pulmonary diseases, cardiovascular diseases, among others. It also offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems, and specialty pharmacies. Chiesi USA is headquartered in Cary, North Carolina, the US.

Gain a 360-degree view of Chiesi USA Inc and make more informed decisions for your business Gain a 360-degree view of Chiesi USA Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address Suite 600, 175 Regency Woods Place, Cary, North Carolina, 27518


Telephone 1 888 4666505

Industry Pharmaceuticals and Healthcare

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Chiesi USA Inc premium industry data and analytics

15+

Marketed Drugs

Understand Chiesi USA Inc’s commercialized product portfolio to stay one step ahead of the market.

11+

Clinical Trials

Determine Chiesi USA Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

7

Pipeline Drugs

Identify which of Chiesi USA Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Catalyst Calendar

Proactively evaluate Chiesi USA Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Chiesi USA Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Cardene I.V. (nicardipine hydrochloride) Cardene I.V.
Curosurf (poractant alfa) Curosurf
Pertzye (pancrelipase) Pertzye
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Chiesi USA Inc portfolio and identify potential areas for collaboration Understand Chiesi USA Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Chiesi USA Inc Eloxx Pharmaceuticals Inc Genentech USA Inc Lupin Pharmaceuticals Inc Novartis Pharmaceuticals Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City Cary Watertown South San Francisco Baltimore East Hanover
State/Province North Carolina Massachusetts California Maryland New Jersey
No. of Employees - 18 14,000 - -
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Jon Zwinski Chief Executive Officer; General Manager Senior Management 2021 -
Polly Petrino Vice President - Finance Senior Management 2021 -
Donna White Vice President - Contracts and Compliance Senior Management 2017 -
Richard Smith Vice President Senior Management 2024 -
Marc Claussen Vice President - Business Excellence & Customer Experience Senior Management 2023 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Chiesi USA Inc key executives to enhance your sales strategy Gain insight into Chiesi USA Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?
Start of HubSpot Embed Code End of HubSpot Embed Code